title: Combination treatment with extended-infusion ceftazidime/avibactam for a KPC-3-producing Klebsiella pneumoniae bacteraemia in a kidney and pancreas transplant patient.
authors.forename: David M
authors.initials: DM
authors.lastname: Jacobs
authors.affiliation: Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, 346 Abbott Hall, Buffalo, NY 14214, USA.
authors.forename: Sara
authors.initials: S
authors.lastname: DiTursi
authors.affiliation: Department of Pharmacy, Erie County Medical Center, 462 Grider Street, Buffalo, NY 14215, USA.
authors.forename: Christine
authors.initials: C
authors.lastname: Ruh
authors.affiliation: Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, 346 Abbott Hall, Buffalo, NY 14214, USA.
authors.forename: Rajnikant
authors.initials: R
authors.lastname: Sharma
authors.forename: Jonathan
authors.initials: J
authors.lastname: Claus
authors.affiliation: Division of Infectious Diseases, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14214, USA.
authors.forename: Rashmi
authors.initials: R
authors.lastname: Banjade
authors.affiliation: Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, 346 Abbott Hall, Buffalo, NY 14214, USA. Electronic address: gaurirao@buffalo.edu.
authors.forename: Gauri G
authors.initials: GG
authors.lastname: Rao
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000494:pharmacology; D053961:Azabicyclo Compounds / Q000008:administration & dosage*; D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology; D001426:Bacterial Proteins / Q000378:metabolism*; D002442:Ceftazidime / Q000008:administration & dosage*; D004338:Drug Combinations; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous / Q000379:methods; D016030:Kidney Transplantation; D007710:Klebsiella Infections / Q000188:drug therapy* / Q000382:microbiology; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000201:enzymology* / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D016035:Pancreas Transplantation; D066027:Transplant Recipients; D016896:Treatment Outcome; D014481:United States; D065093:beta-Lactamase Inhibitors / Q000008:administration & dosage*; D001618:beta-Lactamases / Q000378:metabolism*
chemical_list: D000900:Anti-Bacterial Agents; D053961:Azabicyclo Compounds; D001426:Bacterial Proteins; D004338:Drug Combinations; C000595613:avibactam, ceftazidime drug combination; D065093:beta-Lactamase Inhibitors; D002442:Ceftazidime; D001618:beta-Lactamases; C495220:beta-lactamase KPC-3, Klebsiella pneumoniae